Myeloperoxidase uses hydrogen peroxide (H 2 O 2 ) to generate hypochlorous acid (HOCl), a potent cytotoxic oxidant. We demonstrate that HOCl regulates the activity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro, suggesting that this oxidant activates MMPs in the artery wall. Indeed, both MMP-7 and myeloperoxidase were colocalized to lipid-laden macrophages in human atherosclerotic lesions. A highly conserved domain called the cysteine switch has been proposed to regulate MMP activity. When we exposed a synthetic peptide that mimicked the cysteine switch to HOCl, HPLC analysis showed that the thiol residue reacted rapidly, generating a near-quantitative yield of products. Tandem mass spectrometric analysis identified the products as sulfinic acid, sulfonic acid, and a dimer containing a disulfide bridge. In contrast, the peptide reacted slowly with H 2 O 2 , and the only product was the disulfide. Moreover, HOCl markedly activated pro-MMP-7, an MMP expressed at high levels in lipid-laden macrophages in vivo. Tandem mass spectrometric analysis of trypsin digests revealed that the thiol residue of the enzyme's cysteine switch domain had been converted to sulfinic acid. Thiol oxidation was associated with autolytic cleavage of pro-MMP-7, strongly suggesting that oxygenation activates the latent enzyme. In contrast, H 2 O 2 failed to oxidize the thiol residue of the protein or activate the enzyme. Thus, HOCl activates pro-MMP-7 by converting the thiol residue of the cysteine switch to sulfinic acid. This activation mechanism is distinct from the well-studied proteolytic cleavage of MMP pro-enzymes. Our observations raise the possibility that HOCl generated by myeloperoxidase contributes to MMP activation, and therefore to plaque rupture, in the artery wall. HOCl and other oxidants might regulate MMP activity by the same mechanism in a variety of inflammatory conditions.Proteolysis of structural and adhesive matrix proteins by infiltrating cells is a key event in many destructive inflammatory conditions (1). The role of macrophage-derived matrix metalloproteinases (MMPs) 1 in mediating plaque rupture in atherosclerosis provides a physiologically relevant example of this process (2, 3). Formation of a thrombus over a ruptured atherosclerotic plaque precipitates most cases of acute myocardial infarction (4, 5). Atherosclerotic lesions resistant to rupture are stabilized by a fibrous cap, which separates an intensely procoagulant lipid core from the bloodstream. Because the extracellular matrix plays a key structural role in stabilizing this cap, matrix-degrading enzymes, and MMPs, in particular, might contribute to plaque instability (1-5). Indeed, the lipidladen macrophages that congregate in the shoulder regions of human atherosclerotic lesions express several MMPs: collagenase-1 (MMP-1), stromelysin-1 (MMP-3), and gelatinase B (MMP-9) (6 -8). In contrast, expression of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) is confined to lipidladen macrophages on the border of the acellular lipid core...